The European Union (EU) has been a long-standing and strategic partner of Gavi, contributing more than €3 billion (US$ 3.6 billion) since 2003 in support of immunisation programmes and stronger health systems worldwide. The partnership is built on a shared commitment to equitable access to vaccines, global health security and sustainable development.
The European Union played a key role in supporting the Gavi COVAX AMC during the COVID-19 pandemic, providing €775 million (US$ 1.0 billion) in grant funding from 2020 through 2022; and working with the European Investment Bank (EIB) to mobilise additional financing and guarantees. This helped expand access to COVID-19 vaccines in low- and middle-income countries, strengthen global health security, and advance vaccine delivery and roll-out efforts.
The EU has also played a leading role in supporting Gavi’s work to strengthen vaccine manufacturing capacity in Africa. In June 2024, the EU and its Member States announced support of more than €750 million (approximately US$ 864 million) for Gavi’s African Vaccine Manufacturing Accelerator (AVMA), including more than €200 million (approximately US$ 230 million) from the European Commission.
At the Global Summit: Health & Prosperity through Immunisation in Brussels on 25 June 2025, co-hosted by the European Union and the Gates Foundation, the EU reaffirmed its previous commitment of €260 million (approximately US$ 299 million) announced at the 2024 UN General Assembly and made a total pledge of €360 million (approximately US$ 414 million) for the Gavi 6.0 strategic period (2026–2030). This formed part of a broader Team Europe pledge of more than €2 billion comprising contributions from the EU and its Member States.
The EU also supports Gavi through its partnership with the European Investment Bank (EIB), which has provided €600 million in surge financing and has since expanded to offer up to €1 billion in liquidity support for vaccine procurement and immunisation programmes, including emergency response needs.
As of 30 June 2024
Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Notes:
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000–2023 and Q1-Q2 2024 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2023 and Q1-Q2 2024, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the applicable “forecast rates” from Bloomberg as of 30 June 2024 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the “spot rates” from Refinitiv as at 30 June 2024 or using the rates applicable to any hedge agreement in place.
IFFIm contributions
Received contributions: non-US$ contributions for 2000–2023 and for Q1-Q2 2024 are expressed in US$ equivalents as confirmed by the World Bank Group’s International Bank for Reconstruction and Development (IBRD).
Future contributions: non-US$ contributions for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents as follows:
General notes regarding IFFIm contributions:
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the donor’s amount due, in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund (IMF). Since 29 June 2021, no reduction applies, as all countries from the reference portfolio have cleared their arrears with the IMF.